Wave Life Sciences Ltd. Y95308105 08/05/2025 To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 1305356 0 FOR 1305356 FOR Wave Life Sciences Ltd. Y95308105 08/05/2025 To approve, on a non-binding, advisory basis only, the frequency of holding future shareholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 1305356 0 FOR 1305356 FOR UroGen Pharma Ltd. 000M96088 08/26/2025 To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 18064452 0 WITHOLD 18064452 NONE UroGen Pharma Ltd. 000M96088 08/26/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. SECTION 14A SAY-ON-PAY VOTES 102837 0 WITHOLD 102837 NONE Biohaven Ltd 000G1110E 04/28/2026 A non-binding advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 702884 0 WITHOLD 702884 NONE Amarin Corporation 000023111 05/13/2026 Ordinary resolution to approve, on a non-binding, advisory basis, the compensation of the Company's "named executive officers" for the fiscal year ended December 31, 2025 as described on pages 34 to 66 of the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 328972 0 WITHOLD 328972 NONE Nurix Therapeutics, Inc. 00067080M 05/15/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 473485 0 WITHOLD 473485 NONE Travere Therapeutics, Inc. 00089422G 05/19/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 18064452 0 WITHOLD 18064452 NONE Travere Therapeutics, Inc. 00089422G 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 1279898 0 WITHOLD 1279898 NONE Geron Corporation 000374163 05/20/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 3649660 0 WITHOLD 3649660 NONE Vera Therapeutics, Inc. 00092337R 05/21/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 3337893 0 WITHOLD 3337893 NONE Immunocore Holdings PLC 00045258D 05/27/2026 To approve, on advisory basis, the compensation of our named executive officers, as disclosed in the attached proxy statement. SECTION 14A SAY-ON-PAY VOTES 884937 0 WITHOLD 884937 NONE Viridian Therapeutics 00092790C 06/02/2026 To approve, on an advisory basis, the frequency of holding an advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 3098943 0 1 YEAR 3098943 FOR Viridian Therapeutics 00092790C 06/02/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 3498052 0 FOR 3498052 FOR Beam Therapeutics Inc. 00007373V 06/03/2026 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 1570747 0 WITHOLD 1570747 NONE Sutro Biopharma, Inc 000869367 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 872558 0 WITHOLD 872558 NONE Cogent Biosciences, Inc. 00019240Q 06/09/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 3726686 0 WITHOLD 3726686 NONE Prelude Therapeutics Incorporated 00074065P 06/09/2026 Advisory vote on the frequency of advisory votes on named executive officer compensation (say-on-frequency). SECTION 14A SAY-ON-PAY VOTES 18064452 0 WITHOLD 18064452 NONE Prelude Therapeutics Incorporated 00074065P 06/09/2026 Advisory vote to approve the 2025 compensation for the company's named executive officers (say-on-pay). SECTION 14A SAY-ON-PAY VOTES 1592551 0 WITHOLD 1592551 NONE Relay Therapeutics, Inc. 00075943R 06/09/2026 To consider and act upon an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 525073 0 WITHOLD 525073 NONE Syndax Pharmaceuticals, Inc 00087164F 06/10/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES 7916360 0 WITHOLD 7916360 NONE Biocryst Pharmaceuticals, Inc. 00009058V 06/11/2026 To hold a non-binding, advisory vote regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES 3498052 0 FOR 3498052 FOR Vaxcyte, Inc. 00092243G 06/15/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 1975153 0 WITHOLD 1975153 NONE Cullinan Therapeutics, Inc. 000230031 06/16/2026 Proposal to vote, on an advisory basis, to approve our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 1808334 0 WITHOLD 1808334 NONE Alector, Inc. 000014442 06/17/2026 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES 1806555 0 WITHOLD 1806555 NONE Cytomx Therapeutics, Inc. 00023284F 06/17/2026 To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 3098943 0 1 YEAR 3098943 FOR Cytomx Therapeutics, Inc. 00023284F 06/17/2026 To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. SECTION 14A SAY-ON-PAY VOTES 18064452 0 FOR 18064452 FOR UroGen Pharma Ltd. 000M96088 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. SECTION 14A SAY-ON-PAY VOTES 1923410 0 WITHOLD 1923410 NONE Celldex Therapeutics, Inc. 00015117B 06/25/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 5732474 0 WITHOLD 5732474 NONE